• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Cepheid, BioGX Partner to Create GeneXpert Monkeypox Test

    Siemens' Varian Gains FDA IDE Nod for FAST-02 Trial

    Acutus Medical Launches AcQCross Line Extension

    Accelmed Partners II, Lauxera Capital Partners Invest in Veranex

    Agnes Lee Named SVP of Investor Relations, Strategic Planning at Inogen
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Theranos Fraud Trial, Part II: The Blame Game Continues

    An Update on Surgical Robotics

    Letting the Light In: How Failure Analysis is the Cornerstone of Success

    Three Talent Strategies to Attract High-Demand Skills

    The Advantages of Bioburden Screening for Sterilization Validation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    BMP Medical

    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Investment in Health Startups Drops

    The Power of Leveraging Customer Relationships

    Cost Effective & Efficient Wire EDM Techniques

    How MedTech Professionals Can Help Combat Physician Burnout

    How to Optimize Manufacturing Lines and Choose Which Machines to Buy
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    BMP Medical

    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Tips for Protecting Intellectual Property to Secure Funding

    This column provides tips on how to ensure a medtech company’s other valuable intellectual property is ready for due diligence.

    Tips for Protecting Intellectual Property to Secure Funding
    Roman Fayerberg, David J. Dykeman, Todd Basile, Registered Patent Attorneys, Greenberg Traurig LLP07.22.21
    Intellectual property due diligence is a critical step of any acquisition or investment process. In our previous MPO column, we provided tips for preparing for and passing patent due diligence. In addition to patents, medtech companies utilize other types of intellectual property, such as software, data protection, and trade secrets to distinguish themselves from the competition. This column provides tips on how to ensure a medtech company’s other valuable intellectual property is ready for due diligence.

    Software
    As medical diagnoses and treatments evolve, software is moving to the forefront of the medtech industry. The use of augmented reality to assist in surgery, the use of artificial intelligence in diagnostics, and robotic surgeries are becoming more commonplace. For companies in this space, software is an important asset, and the investors will want to make sure proprietary software is adequately protected.

    One of the most scrutinized issues in software due diligence is ownership. Companies increasingly outsource development to contractors and adopt customer suggestions for new features and functionality. It may seem natural that the company would own the resulting code and intellectual property, but disputes often arise if ownership rights are not clearly documented. Accordingly, agreements with employees, developers, customers, and end users should each include assignment provisions conveying any ownership rights these parties may have to the company.

    Investors also frequently explore how open source software (OSS) and third-party software and libraries (collectively “third-party components”) are used in a company’s proprietary software. It is important for companies to ensure such use complies with the licensing terms and conditions associated with each third-party component, otherwise significant issues could arise. For example, some OSS is subject to copyleft licensing terms that may force software companies to publish their source code and/or provide their software to the public for free. Removing OSS often involves costly redesigns to avoid potential copyright infringement going forward. Companies should track their use of OSS and third-party software and ensure its agreements require developers to adhere to the company’s policies and identify all such software components included in their deliverables.

    Another issue is the protection of the proprietary software. In light of the U.S. Supreme Court’s decision in Alice Corp. vs. CLS Bank, it has become more difficult to obtain patent protection for software.

    Nevertheless, working with a knowledgeable patent counsel can assist companies to secure patents for its software innovations. To supplement patents, companies should also consider relying on copyrights to protect software code and proprietary libraries or databases.

    Data
    Medtech companies often derive valuable insights about their products using data collected by connected medical devices. As such, a company’s data can be one of its most valuable intellectual property assets and investors will want to confirm the data is adequately protected.

    As with software, one of the most important considerations with respect to proprietary data is ownership. Companies should update their terms and conditions to ensure the company owns all such data, or at least has patients’ permission to use information collected for the purposes envisioned by the company. Because data is often collected from medical devices and may include personal identifiable information of patients, medtech companies should also ensure their software meets data security and privacy guidelines. Non-compliance with privacy regulations such as HIPAA and European General Data Protection Regulation (GDPR) may result in civil or even criminal liabilities, and could become an issue in due diligence.

    Trade Secrets
    Trade secrets are another valuable asset reviewed during diligence by medtech investors. A medtech company’s success is often attributable to its confidential information and know-how. Accordingly, investors want to see companies implementing strong safeguards and policies to keep valuable information proprietary to the company.

    At a minimum, companies should ensure that all employees, contractors, visitors, and potential partners sign written non-disclosure agreements (NDA). A well-drafted NDA will not only require the recipient of confidential information to avoid disclosure to third parties, but also will constrain the recipient’s use of the confidential information to a limited purpose (e.g., evaluating the compatibility of the company’s technology with the recipient’s product). This tends to make recipients more mindful of protecting the company’s information.

    Even with such safeguards in place, companies should also implement procedures to restrict access to its trade secrets on a “need-to-know” basis. For example, companies may configure their IT systems so certain technical information is accessible only to engineers or scientists that need such information to perform their job and is not accessible to other departments. Likewise, software-related trade secrets can be protected by providing customers and authorized third parties with access only to application programming interfaces and executable files, and no access to the underlying source code, libraries, and databases where a company’s “secret sauce” typically resides. Finally, if a situation arises when the trade secrets need to be disclosed, for example, as part of a joint venture, the companies should have procedures ensuring that trade secrets are disclosed only to the extent absolutely necessary and only after executing a strong NDA.

    IP Licenses
    Many medtech companies utilize third-party intellectual property in their everyday business. Typical licensed intellectual property includes patents and software, but all types of intellectual property can be licensed.

    One issue that typically arises in connection with IP licenses is the scope of rights granted by the license. For example, a licensee should make sure the licensed field of use and territory cover not only the current, but also contemplated, uses and markets. Other important provisions that typically determine the value of the license are the term of the license, ability of licensee to freely sublicense or assign the license, financial obligations (royalty rates and milestone payments) required by the license, ownership of improvements, and the ability of licensor to terminate the license. A medtech company seeking investment should review its IP licenses and address these issues before they are raised by investors.

    Conclusion
    To prepare for due diligence, a medtech company should periodically audit its intellectual property assets to ensure that it (1) fully owns its proprietary software, that such software is protected and is in compliance with privacy and cybersecurity laws and practices, (2) has a trade secret policy, and (3) has IP licenses providing the necessary scope of rights that will not be impacted by the investment or acquisition. Finding and fixing potential IP issues ahead of time should help investors gain confidence in the target company and expedite the due diligence process. 


    Roman Fayerberg is a registered patent attorney with more than 15 years of experience in patent and IP law. He advises clients on procurement and enforcement of IP rights, including domestic and international patents, with the focus on robotics, medtech and life science technologies. He can be reached at fayerbergr@gtlaw.com.

    David J. Dykeman is a registered patent attorney with nearly 25 years of experience in patent and IP law and is co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group. Dykeman’s practice focuses on securing worldwide intellectual property protection and related business strategy for high-tech clients, with particular experience in medical devices, robotics, wearables, life sciences, and information technology. He can be reached at dykemand@gtlaw.com.

    Todd Basile is a registered patent attorney with more than 15 years of combined experience in the tech and legal industries. He helps technology companies protect and commercialize their innovations and brands across various industries including medtech, robotics, and software. He also represents technology investors in M&A deals, negotiates technology transactions, and assists clients in navigating IP disputes. He can be reached at basilet@gtlaw.com.
    Loading, Please Wait..

    Trending
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • FDA OKs J&J Vision's AcuVue Oasys Max 1-Day Contact Lenses
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • Intermountain Healthcare & Siemens Healthineers Open 3 Tellica Outpatient Imaging Centers
    • Labcorp Launches At-Home Collection Device For Diabetes Risk Testing
    Breaking News
    • Cepheid, BioGX Partner to Create GeneXpert Monkeypox Test
    • Siemens' Varian Gains FDA IDE Nod for FAST-02 Trial
    • Acutus Medical Launches AcQCross Line Extension
    • Accelmed Partners II, Lauxera Capital Partners Invest in Veranex
    • Agnes Lee Named SVP of Investor Relations, Strategic Planning at Inogen
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • OEMs Seek Molders Offering Timely Techniques
    • Robotic Surgery: Cutting Through to the Latest
    • Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
    Shiitake Mushroom Extract Appears Helpful in HPV Infections
    Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected
    Coatings World

    Latest Breaking News From Coatings World

    H.M. Royal Becomes Exclusive OCSiAl Distributor
    American Colors to Expand Sandusky, Ohio Facility
    Vaughn O’Dea Named Director of Epoxytec
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cepheid, BioGX Partner to Create GeneXpert Monkeypox Test
    Siemens' Varian Gains FDA IDE Nod for FAST-02 Trial
    Acutus Medical Launches AcQCross Line Extension
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate
    Pfizer, BioNTech Adapt COVID Vax Against Omicron
    CoreRx Expands Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top 5 Beauty Tech Trends at Perfect Corp.'s Global Forum
    John Frieda Supports the LGBTQIA+ Community
    Athena Club Launches in Canada
    Happi

    Latest Breaking News From Happi

    Fencing Champion Bebe Vio Grandis Named Spokeswoman of L’Oréal Paris
    Past Henkel Exec Christian Chopra Named President of Scotch Porter
    Color Street Celebrates Foster, Adoption Awareness with Limited-Edition Print
    Ink World

    Latest Breaking News From Ink World

    Dr. Tammo Boinowitz to Join Management Board of ALTANA AG
    Flint Offset Packaging Solutions Announces Price Increases for Sheetfed Inks
    Weekly Recap: INX’s VC Fund, Screen Industry and Ball Top This Week’s News
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Harveer Sahni recognized with Global Achievement Award
    Color-Logic partners with Taktiful 
    ALTANA announces Management Board change
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Fibertex Personal Care Awarded EcoVadis Awards for Sustainability
    Yanpai Orders Batt Forming Equipment for Needlepunch Line
    Weekly Recap: SWM and Neenah Introduce Mativ Inc., Avgol honored for Biotransformation Technology & More
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Researchers Discover Novel Patching Material for Bone Defects
    Boston Centerless Opens Second Manufacturing Plant in Indiana
    Researchers Develop Patient-Specific 3D-Printed Smart Metamaterial Implants
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv-Powered CVS Spoken Rx Wins NFC Forum 2022 Innovation Award
    LG Display Announces Winners of This Year’s OLEDs GO! Competition
    Weekly Recap: eMagin, Applied Materials, and Schott Top This Week’s Stories

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login